Katrin Sikk

Dr. Katrin Sikk

orcid

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2007 in Acta Neurologica Scandinavica
Verified
Journal Article
Closed access
PDF file
KSKatrin Sikk
Katrin Sikk
PTP. Taba
P. Taba
SHS. Haldre
S. Haldre
JBJonas Bergquist
Jonas Bergquist
DND. Nyholm
D. Nyholm
SAS.-M. Aquilonius
S.-M. Aquilonius
Parkinsonian syndrome related to intravenous use of a "designer" psychostimulant, derived from pseudoephedrine using potassium permanganate as the oxidant, has been observed in drug addicts in Estonia. To describe the symptomatology of four young patients, history of drug administration and chemical analysis of a drug batch. Mental and motor function and quality of life were scored and ephedrone was analyzed using electrospray mass spectrometry. Manganese content of the final synthetic mixture was analyzed using Inductively Coupled Plasma-Atomic Emission Spectrometry. None of the four cases scored below the dementia threshold in MMSE, while other ratings (UPDRS, H&Y, PDQ-39) corresponded to disabilities seen in relatively advanced Parkinson's disease. The ephedrone yield of the reaction was approximately 44% and the mixture was found to contain 0.6 g/l of manganese. The cases were exposed to extreme manganese load. Their symptomatology is probably identical to manganism. The role of ephedrone is presently unknown. Physicians must be aware of early signs of manganism in patients within social risk groups.

1 January 2011 in Parkinson's Disease
Verified
Journal Article
Open access
PDF file
KSKatrin Sikk
Katrin Sikk
SHSulev Haldre
Sulev Haldre
SASten-Magnus Aquilonius
Sten-Magnus Aquilonius
PTPille Taba
Pille Taba
During recent years, a syndrome of hypokinesia, dysarthria, dystonia, and postural impairment, related to intravenous use of a “designer” psychostimulant derived from pseudoephedrine using potassium permanganate as the oxidant, has been observed in drug addicts in several countries in Eastern Europe with some cases also in Western countries. A levodopa unresponsive Parkinsonian syndrome occurs within a few months of abusing the homemade drug mixture containing ephedrone (methcathinone) and manganese. The development of this neurological syndrome has been attributed to toxic effects of manganese, but the role of the psychostimulant ephedrone is unclear. This paper describes the clinical syndrome, results of neuroimaging, and therapeutic attempts.

24 January 2013 in European Journal of Neurology
Verified
Journal Article
Closed access
PDF file
KSKatrin Sikk
Katrin Sikk
SHS. Haldre
S. Haldre
SAS.‐M. Aquilonius
S.‐M. Aquilonius
AAA. Asser
A. Asser
MPM. Paris
M. Paris
PTP. Taba
P. Taba

5 March 2010 in Acta Neurologica Scandinavica
Verified
Journal Article
Closed access
PDF file
KSKatrin Sikk
Katrin Sikk
PTP. Taba
P. Taba
SHS. Haldre
S. Haldre
JBJonas Bergquist
Jonas Bergquist
DND. Nyholm
D. Nyholm
SAS.-M. Aquilonius
S.-M. Aquilonius
Sikk K, Taba P, Haldre S, Bergquist J, Nyholm D, Askmark H, Danfors T, Sörensen J, Thurfjell L, Raininko R, Eriksson R, Flink R, Färnstrand C, Aquilonius S-M. Clinical, neuroimaging and neurophysiological features in addicts with manganese-ephedrone exposure. Acta Neurol Scand: 2010: 121: 237–243.© 2009 The Authors Journal compilation © 2009 Blackwell Munksgaard. Objective – To identify biomarkers supporting the clinical diagnosis of manganism in patients several years after exposure to manganese (Mn). Methods – Neurophysiological examinations, magnetic resonance imaging (MRI), single-photon emission computed tomography and fluorodeoxyglycose (FDG) positron emission tomography were performed in four former ephedrone addicts with extrapyramidal symptoms. Results – Peripheral nervous system was not affected. No patients had reduced uptake of 123I Ioflupane in the striatum. MRI signal intensities were slightly changed in the basal ganglia. All patients showed a widespread, but not uniform, pathological pattern of FDG uptake with changes mainly located to the central part of the brain including the basal ganglia and the surrounding white matter. Conclusions – Presynaptic neurons in the nigrostriatal pathway are intact in Mn-induced parkinsonism after prolonged abstinence from ephedrone. The diagnosis is principally based on clinical signs and the history of drug abuse.

1 January 2011 in Frontiers in Genetics
Verified
Journal Article
Open access
PDF file
KSKatrin Sikk
Katrin Sikk
Sulev KoksSulev Koks
Sulev Koks
USUrsel Soomets
Ursel Soomets
LSLeonard C. Schalkwyk
Leonard C. Schalkwyk
CFCathy Fernandes
Cathy Fernandes
PTPille Taba
Pille Taba
Methcathinone (ephedrone) is relatively easily accessible for abuse. Its users develop an extrapyramidal syndrome and it is not known if this is caused by methcathinone itself, by side-ingredients (manganese), or both. In the present study we aimed to clarify molecular mechanisms underlying this condition. We used microarrays to analyze whole-genome gene expression patterns of peripheral blood from 20 methcathinone users and 20 matched controls. Gene expression profile data were analyzed by Bayesian modeling and functional annotation. Of 28,869 genes on the microarrays, 326 showed statistically significant differential expression with FDR adjusted p-values below 0.05. Quantitative real-time PCR confirmed differential expression for the most of the genes selected for validation. Functional annotation and network analysis indicated activation of a gene network that included immunological disease, cellular movement, and cardiovascular disease functions (enrichment score 42). As HIV and HCV infections were confounding factors, we performed additional stratification of subjects. A similar functional activation of the “immunological disease” category was evident when we compared subjects according to injection status (past versus current users, balanced for HIV and HCV infection). However, this difference was not large therefore the major effect was related to the HIV status of the subjects. Mn–methcathinone abusers have blood RNA expression patterns that mostly reflect their HIV and HCV infections.

29 December 2025 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
AKAndres Köster
Andres Köster
DHDao Anh Hoang
Dao Anh Hoang
ADAndrey Dashuk
Andrey Dashuk
HVHeisl Vaher
Heisl Vaher
KSKatrin Sikk
Katrin Sikk
TJTriin Jagomägi
Triin Jagomägi
Background: Orofacial myofunctional therapy (OMT) is an emerging adjunctive treatment for obstructive sleep apnea (OSA), but its effects on upper airway structural support, particularly the hyoid complex, are not well defined. This study assessed the short-term effects of OMT on hyoid bone position and sleep-related indices in adults with mild to moderate OSA. Methods: In this assessor-blinded randomized controlled trial (ClinicalTrials.gov Identifier: NCT06079073), 13 adults with mild to moderate OSA were randomized to a 12-week web-based OMT program (n = 9) or a waitlist control group (n = 4). Cone-beam computed tomography (CBCT) and three-night home sleep testing were performed at baseline and follow-up. The primary outcome was change in axis-based cephalometric hyoid position measures; secondary outcomes included sleep parameters such as the apnea–hypopnea index (AHI). Results: No significant within- or between-group differences were observed in AHI, oxygen desaturation index, or mean nocturnal SpO2 after 12 weeks (all p > 0.05). However, several cephalometric variables showed significant between-group differences. The waitlist group exhibited greater posterior–inferior hyoid displacement than the OMT group, with large effect sizes across multiple vector measures (all p ≤ 0.045; r = 0.56–0.66). Posterior and inferior hyoid displacement was associated with higher AHI and lower SpO2, whereas increased lower pharyngeal airway width was associated with lower AHI. Conclusions: Short-term OMT did not improve sleep-disordered breathing indices but was associated with stabilization of hyoid bone position. These findings suggest that structural stabilization may precede functional improvement and highlight the clinical relevance of vector-based hyoid analysis.